MedPath

Gallstones and Risk of Inflammatory Bowel Disease

Completed
Conditions
Inflammatory Bowel Diseases
Interventions
Other: gallstones
Registration Number
NCT05882006
Lead Sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Brief Summary

The purpose of this study was to evaluate the association between gallstone disease and the risk of inflammatory bowel disease.

Detailed Description

Crohn's disease and ulcerative colitis , collectively known as inflammatory bowel diseases , have increased substantially over the past few decades affecting nearly 6.8 million individuals worldwide. The etiology of IBD remains obscure, possibly involving a complex interaction between the genetic, environmental or microbial factors and the immune responses. Gallstone disease is one of the most common and costly gastroenterological disorders, with a prevalence of 10-20% in Europe and America. Considering that gallstones and IBD also share specific risk factors, such as obesity, inappropriate diet and metabolic hormone levels, and have the pathophysiologic linkage, such as changes in gut microbiota composition and bile acid profile, the investigators propose that the occurrence of gallstones may predict the subsequence risk of IBD. However, investigations concerning the association is lacking.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5035
Inclusion Criteria
  • Age between 18 and 90 years old
  • IBD established by standard criteria, either Crohn's disease or ulcerative colitis
Exclusion Criteria
  • Pregnant or nursing woman;
  • Prior abdominal surgery related to IBD, such as subtotal or total colectomy;
  • HIV infection or any congenital immunodeficiency at the time of inclusion;
  • Post organ transplant patients;
  • Patients suffering from cancer currently or in the past;
  • Patients suffering from significant cardiovascular disease;
  • Patients suffering from significant respiratory diseases;
  • Patients suffering from any other chronic severe diseases.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
casesgallstonesIBD patients (including Crohn's disease and Ulcerative colitis)
controlsgallstonesAge, sex, and calendar-year matched controls sampled from non-IBD patients to be a round number of at least four times the number of cases
Primary Outcome Measures
NameTimeMethod
The odds ratio of the association between the presence of gallstone disease and risk of inflammatory bowel disease10 years

The odds ratio is a ratio of two sets of odds: the odds in case group (gallstone diseases with IBD divided by non-gallstone disease with IBD) versus the odds in control group (gallstone diseases without IBD divided by non-gallstone disease without IBD). Finally, we can calculate the odds ratio by dividing the ratio of the case group by the ratio of the control group.

The prevalence of gallstone disease among patients with or without IBD10 years

We assess the prevalence as the number of gallstone diseases divided by the number of IBD patients or non-IBD patients. Gallstone disease was diagnosed as presence of gallstones, cholecystectomy, choledocholithotomy and Endoscopic Retrograde Cholangio-Pancreatography (ERCP).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Hepatopancreatobiliary Surgery Institute of Gansu Province

🇨🇳

Lanzhou, Gansu, China

Lanzhou University Second Hospital

🇨🇳

Lanzhou, Gansu, China

Wuwei Tumor Hospital

🇨🇳

Wuwei, Gansu, China

The Seventh Affiliated Hospital, Sun Yat-Sen University

🇨🇳

Shenzhen, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath